Genes reveal kidney cancer's risk of recurrence

byMcGill UniversityDisease-Free Survival outcomes amongst genomic groups when applied to the 247 VHL mutated ccRCCs from the TCGA dataset. Credit:Clinical Cancer Research(2023). DOI:

Updated on: December 25,2023

Genes reveal kidney cancer's risk of recurrence

byMcGill UniversityDisease-Free Survival outcomes amongst genomic groups when applied to the 247 VHL mutated ccRCCs from the TCGA dataset. Credit:Clinical Cancer Research(2023). DOI:

Updated on:December 25,2023

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho

Updated on: December 18,2023

Major response to immunotherapy in early-stage mismatch repair deficient colon cancer

byEuropean Society for Medical OncologyCredit:Annals of OncologyPre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major patho

Updated on:December 18,2023

Harms reporting is inconsistent across organ cancer guidelines

byAmerican College of PhysiciansCredit: CC0 Public DomainA review of 33 organ-specific cancer screening guidelines has found that the reporting of harms related to screening tests and procedures

Updated on: December 22,2023

Harms reporting is inconsistent across organ cancer guidelines

byAmerican College of PhysiciansCredit: CC0 Public DomainA review of 33 organ-specific cancer screening guidelines has found that the reporting of harms related to screening tests and procedures

Updated on:December 22,2023

Study maps alterations that make melanoma more severe, could lead to better therapies and diagnosis

by André Julião,FAPESPStudy design, resources and methodology. A major aim (steps 1–2) is the discovery and validation of genome-wide methylation alterations associated with the UV mutational si

Updated on: February 20,2024

Study maps alterations that make melanoma more severe, could lead to better therapies and diagnosis

by André Julião,FAPESPStudy design, resources and methodology. A major aim (steps 1–2) is the discovery and validation of genome-wide methylation alterations associated with the UV mutational si

Updated on:February 20,2024

Hodgkin lymphoma survivors show signs of dementia in early adulthood

by Leslie Orr,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainIn a new study, the majority of individuals treated as children for Hodgkin lymphoma who are now in their 30s

Updated on: December 25,2023

Hodgkin lymphoma survivors show signs of dementia in early adulthood

by Leslie Orr,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainIn a new study, the majority of individuals treated as children for Hodgkin lymphoma who are now in their 30s

Updated on:December 25,2023

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations

Updated on: December 25,2023

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations

Updated on:December 25,2023

Method that uses combination of immune cells could provide clearer prognoses

by Elin Bäckström,Swedish Research CouncilPrognostic value of CD8+T cells and CD68+CD163+macrophages revealed by comprehensive characterization of immune cell subsets in 286 therapy-

Updated on: January 04,2024

Method that uses combination of immune cells could provide clearer prognoses

by Elin Bäckström,Swedish Research CouncilPrognostic value of CD8+T cells and CD68+CD163+macrophages revealed by comprehensive characterization of immune cell subsets in 286 therapy-

Updated on:January 04,2024

Mounjaro beats Ozempic for weight loss in early trial

by Robin FosterThe diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report.Both Mounjaro (tirzepatide) and Ozemp

Updated on: March 06,2024

Mounjaro beats Ozempic for weight loss in early trial

by Robin FosterThe diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report.Both Mounjaro (tirzepatide) and Ozemp

Updated on:March 06,2024

The obesity paradox in lung cancer diagnosis may differ by race

by Makhari Dysart,Thomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer death in the U.S., making up 25% of cancer deaths. With obesity rates sim

Updated on: December 22,2023

The obesity paradox in lung cancer diagnosis may differ by race

by Makhari Dysart,Thomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer death in the U.S., making up 25% of cancer deaths. With obesity rates sim

Updated on:December 22,2023

A machine learning tool can help with diagnosing, monitoring colorectal cancer

Updated on: June 18,2025

A machine learning tool can help with diagnosing, monitoring colorectal cancer

Updated on:June 18,2025

Radiation therapy outcomes better for African-American than Caucasian prostate cancer patients

byAmerican Society for Radiation OncologyWhile popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than Caucasian men, a new an

Updated on: December 18,2023

Radiation therapy outcomes better for African-American than Caucasian prostate cancer patients

byAmerican Society for Radiation OncologyWhile popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than Caucasian men, a new an

Updated on:December 18,2023

Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

by Peter Rüegg,ETH ZurichBone-marrow cells of a multiple myeloma patient. Red cells are healthy monocytes, green and yellow are plasma cells. Credit: Berend Snijder Lab / ETH ZurichMultiple myel

Updated on: February 20,2024

Testing hundreds of therapeutics outside the body to predict their effectiveness against multiple myeloma

by Peter Rüegg,ETH ZurichBone-marrow cells of a multiple myeloma patient. Red cells are healthy monocytes, green and yellow are plasma cells. Credit: Berend Snijder Lab / ETH ZurichMultiple myel

Updated on:February 20,2024